Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; YI-CHIA LEE ; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; WEN-FENG HSU ; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; CHIEH-CHANG CHEN ; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; CHIA-TUNG SHUN ; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease and Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; MING-SHIANG WU ; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | 7 | 9 | |
2018 | 14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial | JYH-MING LIOU ; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Antimicrobial Chemotherapy | | 9 | |
2017 | Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers | YI-CHIA LEE ; Chen S.L.-S.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Chuang S.-L.; Chiang T.-H.; Chou C.-K.; Chiu H.-M.; Wu M.-S.; Wu C.-Y.; Chia S.-L.; Chiou S.-T.; Chen H.-H. | Journal of the National Cancer Institute | 30 | 26 | |
2017 | Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers | Lee Y.-C.; Chen S.L.-S.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Chuang S.-L.; Chiang T.-H.; Chou C.-K.; Chiu H.-M.; Wu M.-S.; Wu C.-Y.; Chia S.-L.; Chiou S.-T.; Chen, Tony Hsiu Hsi | Journal of the National Cancer Institute | 30 | 26 | |
2017 | Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers | Lee Y.-C.; Chen S.L.-S.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Chuang S.-L.; Chiang T.-H.; Chou C.-K.; Chiu H.-M.; MING-SHIANG WU ; Wu C.-Y.; Chia S.-L.; Chiou S.-T.; Chen H.-H. | Journal of the National Cancer Institute | 30 | 26 | |
2017 | Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers | Lee Y.-C.; Chen S.L.-S.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Chuang S.-L.; Chiang T.-H.; Chou C.-K.; HAN-MO CHIU ; Wu M.-S.; Wu C.-Y.; Chia S.-L.; Chiou S.-T.; Chen H.-H. | Journal of the National Cancer Institute | | 26 | |
2017 | Association Between Colorectal Cancer Mortality and Gradient Fecal Hemoglobin Concentration in Colonoscopy Noncompliers | Lee Y.-C.; Chen S.L.-S.; Yen A.M.-F.; Chiu S.Y.-H.; Fann J.C.-Y.; Chuang S.-L.; TSUNG-HSIEN CHIANG ; Chou C.-K.; Chiu H.-M.; Wu M.-S.; Wu C.-Y.; Chia S.-L.; Chiou S.-T.; Chen H.-H. | Journal of the National Cancer Institute | 30 | 26 | |
2016 | Association between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic review and Meta-analysis | Lee Y.-C.; Chiang T.-H.; Chou C.-K.; Tu Y.-K.; Liao W.-C.; MING-SHIANG WU ; Graham D.Y. | Gastroenterology | 384 | 402 | |
2016 | Association between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis | Lee Y.-C.; Chiang T.-H.; Chou C.-K.; Tu Y.-K.; WEI-CHIH LIAO ; Wu M.-S.; Graham D.Y. | Gastroenterology | | 402 | |
2016 | Association between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic review and Meta-analysis | Lee Y.-C.; TSUNG-HSIEN CHIANG ; Chou C.-K.; Tu Y.-K.; Liao W.-C.; Wu M.-S.; Graham D.Y. | Gastroenterology | 379 | 404 | |
2016 | Association between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic review and Meta-analysis | YI-CHIA LEE ; Chiang T.-H.; Chou C.-K.; Tu Y.-K.; Liao W.-C.; Wu M.-S.; Graham D.Y. | Gastroenterology | | 402 | |
2016 | Association between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis | Lee Y.-C.; Chiang T.-H.; Chou C.-K.; YU-KANG TU ; Liao W.-C.; Wu M.-S.; Graham D.Y. | Gastroenterology | | 402 | |
2014 | Carbon dioxide insufflation can significantly reduce toilet use after colonoscopy: A double-blind randomized controlled trial | Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Lai H.-H.; Chen M.-K.; Chang L.-C.; Tu C.-H.; Chou C.-K.; HSIU-PO WANG ; Wu M.-S.; Chiu H.-M. | Endoscopy | 16 | 14 | |
2014 | Carbon dioxide insufflation can significantly reduce toilet use after colonoscopy: A double-blind randomized controlled trial | WEN-FENG HSU ; Hu W.-H.; Chen Y.-N.; Lai H.-H.; Chen M.-K.; Chang L.-C.; Tu C.-H.; Chou C.-K.; Wang H.-P.; Wu M.-S.; Chiu H.-M. | Endoscopy | 16 | 14 | |
2014 | Carbon dioxide insufflation can significantly reduce toilet use after colonoscopy: A double-blind randomized controlled trial | Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Lai H.-H.; Chen M.-K.; Chang L.-C.; Tu C.-H.; Chou C.-K.; Wang H.-P.; MING-SHIANG WU ; Chiu H.-M. | Endoscopy | 16 | 14 | |